National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Department of TB/AIDS Control, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China.
Virus Res. 2024 Jul;345:199377. doi: 10.1016/j.virusres.2024.199377. Epub 2024 Apr 29.
The membrane-proximal external region (MPER) represents a highly conserved region of the Human Immunodeficiency Virus (HIV) envelope glycoprotein (env) targeted by several broadly neutralizing antibodies (bnAbs). In this study, we employed single genome amplification to amplify 34 full-length env sequences from the 2005 plasma sample of CBJC504, a chronic HIV-1 clade B infected individual. We identified three amino acid changes (N671S, D674N, and K677R) in the MPER. A longitudinal analysis revealed that the proportion of env sequences with MPER mutations increased from 26.5 % in 2005 to 56.0 % in 2009, and the sequences with the same mutation clustered together. Nine functional pseudoviruses were generated from the 34 env sequences to examine the effect of these mutations on neutralizing activity. Pseudoviruses carrying N674 or R677 mutations demonstrate increased sensitivity to autologous plasma and monoclonal antibodies 2F5, 4E10, and 10E8. Reverse mutations were performed in env including N674, R677, D659, and S671/N677 mutations, to validate the impact of the mutations on neutralizing sensitivity. Neutralization assays indicated that the N671S mutation increased neutralization sensitivity to 2F5 and 10E8. The amino acid R at position 677 increased viral resistance to 10E8, whereas N enhanced viral resistance to 4E10 and 10E8. It has been proposed that critical amino acids in the extra-MPER and the number of potential N-like glycosylation sites (PNGSs) in the V1 loop may have an impact on neutralizing activity. Understanding the mutations and evolution of MPER in chronically infected patients with HIV-1 is crucial for the design and development of vaccines that trigger bnAbs against MPER.
膜近端外区 (MPER) 是人类免疫缺陷病毒 (HIV) 包膜糖蛋白 (env) 的一个高度保守区域,多个广谱中和抗体 (bnAb) 以此为靶标。在这项研究中,我们采用单基因组扩增技术,从慢性 HIV-1 感染个体 CBJC504 于 2005 年的血浆样本中扩增出 34 条全长 env 序列。我们在 MPER 中发现了三个氨基酸变化(N671S、D674N 和 K677R)。纵向分析显示,MPER 突变的 env 序列比例从 2005 年的 26.5%增加到 2009 年的 56.0%,且具有相同突变的序列聚集在一起。我们从这 34 条 env 序列中生成了 9 个功能性假病毒,以研究这些突变对中和活性的影响。携带 N674 或 R677 突变的假病毒对自身血浆和单克隆抗体 2F5、4E10 和 10E8 的敏感性增加。我们在 env 中进行了反向突变,包括 N674、R677、D659 和 S671/N677 突变,以验证突变对中和敏感性的影响。中和试验表明,N671S 突变增加了 2F5 和 10E8 的中和敏感性。位置 677 的氨基酸 R 增加了病毒对 10E8 的抗性,而 N 增强了病毒对 4E10 和 10E8 的抗性。有人提出,额外的 MPER 中的关键氨基酸和 V1 环中潜在的 N 样糖基化位点(PNGSs)的数量可能对中和活性有影响。了解慢性 HIV-1 感染者中 MPER 的突变和进化对于设计和开发针对 MPER 的 bnAb 疫苗至关重要。